Amgen and its global research sites were relying on manual processes – such as emailing or faxing spreadsheets containing de-identified information – to track pre-screening activity at sites.
The manual and fragmented nature of this process led to inefficiencies, reduced Sponsor visibility into real-time pre-screening trends, and ultimately, enrollment challenges. As a consequence, any required decisions to change enrollment strategy were often made further into the enrollment process – causing delays in study execution.
Amgen sought to collaborate with global research sites participating in its clinical trials to increase efficiencies and streamline recruitment and enrollment across their research portfolio.
Download this case study to learn:
How Amgen increased patients enrolled per site, per month by 20%
How sites using StudyTeam are 60% less likely to be zero-enrollers
Why 86% of sites prefer to use StudyTeam over other methods to manage enrollment
Trusted by the largest global biopharmaceutical companies to accelerate clinical trial enrollment. StudyTeam arms you with richer recruitment data that helps you take control of enrollment sooner.
"StudyTeam made tracking enrollment more efficient. We are able to identify I/E criteria that were causing issues or sites and countries that were lagging and take action quickly."
Global Clinical Trial Manager
Amgen
Manage recruitment across all trials, sponsors, or CROs. Enter information once and it automatically goes where you need it to go, eliminating tedious work and freeing you up so you can get back to caring for patients.
86% of research sites working on Amgen trials that have been offered use of StudyTeam have chosen StudyTeam over other methods for managing enrollment.
“StudyTeam gives us visibility into activity at a site enabling us to support and partner with sites to deliver tailored enrollment tools to get more patients into these pivotal trials.”
“I have been a clinical research coordinator for 12 years in Spain, and I have never seen such a complete system. It's actually perfect!”